433 related articles for article (PubMed ID: 9615270)
1. Organ-specific autoimmunity and genetic predisposition in interferon-treated HCV-related chronic hepatitis patients.
Floreani A; Chiaramonte M; Greggio NA; Fabris P; De Lazzari F; Naccarato R; Betterle C
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):71-6. PubMed ID: 9615270
[TBL] [Abstract][Full Text] [Related]
2. Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infection.
Betterle C; Fabris P; Zanchetta R; Pedini B; Tositti G; Bosi E; de Lalla F
Diabetes Care; 2000 Aug; 23(8):1177-81. PubMed ID: 10937518
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
4. Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy.
Marazuela M; García-Buey L; González-Fernández B; García-Monzón C; Arranz A; Borque MJ; Moreno-Otero R
Clin Endocrinol (Oxf); 1996 Jun; 44(6):635-42. PubMed ID: 8759175
[TBL] [Abstract][Full Text] [Related]
5. Development of thyroid autoimmunity after administration of recombinant human interferon-alpha 2b for chronic viral hepatitis.
Chung YH; Shong YK
Am J Gastroenterol; 1993 Feb; 88(2):244-7. PubMed ID: 8424429
[TBL] [Abstract][Full Text] [Related]
6. Islet cell and thyroid antibody prevalence in patients with hepatitis C virus infection: effect of treatment with interferon.
Piquer S; Hernández C; Enriquez J; Ross A; Esteban JI; Genescà J; Bonifacio E; Puig-Domingo M; Simó R
J Lab Clin Med; 2001 Jan; 137(1):38-42. PubMed ID: 11150022
[TBL] [Abstract][Full Text] [Related]
7. [Hepatitis C virus infection and thyroid diseases].
Broussolle C; Steineur MP; Bailly F; Zoulim F; Trépo C
Rev Med Interne; 1999 Sep; 20(9):766-73. PubMed ID: 10522298
[TBL] [Abstract][Full Text] [Related]
8. Temporal relationship between the appearance of thyroid autoantibodies and development of destructive thyroiditis in patients undergoing treatment with two different type-1 interferons for HCV-related chronic hepatitis: a prospective study.
Mazziotti G; Sorvillo F; Stornaiuolo G; Rotondi M; Morisco F; Ruberto M; Cioffi M; Amato G; Caporaso N; Gaeta GB; Carella C
J Endocrinol Invest; 2002; 25(7):624-30. PubMed ID: 12150338
[TBL] [Abstract][Full Text] [Related]
9. [Diabetes mellitus type I, thyroid gland autoimmunity, thyroid gland function and HLA status].
Kehr S; Gastauer R; Winkler G
Monatsschr Kinderheilkd; 1985 Oct; 133(10):738-42. PubMed ID: 3906379
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies in children with chronic hepatitis B infection and the influence of interferon alpha.
Kansu A; Kuloğlu Z; Demirçeken F; Girgin N
Turk J Gastroenterol; 2004 Dec; 15(4):213-8. PubMed ID: 16249973
[TBL] [Abstract][Full Text] [Related]
11. Serological markers of autoimmunity in renal transplant patients before and after alpha-interferon therapy for chronic hepatitis C.
Rostaing L; Oksman F; Izopet J; Baron E; Cisterne JM; Hoff M; Abbal M; Durand D
Am J Nephrol; 1996; 16(6):478-83. PubMed ID: 8955758
[TBL] [Abstract][Full Text] [Related]
12. Induction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon alpha therapy for chronic hepatitis C.
Wesche B; Jaeckel E; Trautwein C; Wedemeyer H; Falorni A; Frank H; von zur Mühlen A; Manns MP; Brabant G
Gut; 2001 Mar; 48(3):378-83. PubMed ID: 11171829
[TBL] [Abstract][Full Text] [Related]
13. Interferon-alpha therapy may induce insulin autoantibody development in patients with chronic viral hepatitis.
di Cesare E; Previti M; Russo F; Brancatelli S; Ingemi MC; Scoglio R; Mazzù N; Cucinotta D; Raimondo G
Dig Dis Sci; 1996 Aug; 41(8):1672-7. PubMed ID: 8769300
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and significance of thyroid autoantibodies in patients with chronic hepatitis C virus infection: a prospective controlled study.
Huang MJ; Tsai SL; Huang BY; Sheen IS; Yeh CT; Liaw YF
Clin Endocrinol (Oxf); 1999 Apr; 50(4):503-9. PubMed ID: 10468911
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of interferon-alpha-induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment.
Carella C; Mazziotti G; Morisco F; Manganella G; Rotondi M; Tuccillo C; Sorvillo F; Caporaso N; Amato G
J Clin Endocrinol Metab; 2001 May; 86(5):1925-9. PubMed ID: 11344186
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune endocrine disease induced by recombinant interferon-alpha therapy for chronic active type C hepatitis.
Imagawa A; Itoh N; Hanafusa T; Oda Y; Waguri M; Miyagawa J; Kono N; Kuwajima M; Matsuzawa Y
J Clin Endocrinol Metab; 1995 Mar; 80(3):922-6. PubMed ID: 7883851
[TBL] [Abstract][Full Text] [Related]
17. The addition of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism.
Carella C; Mazziotti G; Morisco F; Rotondi M; Cioffi M; Tuccillo C; Sorvillo F; Caporaso N; Amato G
Eur J Endocrinol; 2002 Jun; 146(6):743-9. PubMed ID: 12039693
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of organ- and non-organ-specific autoantibodies on the response to anti-viral treatment of patients with chronic hepatitis C.
Gatselis NK; Georgiadou SP; Koukoulis GK; Tassopoulos N; Zachou K; Liaskos C; Hatzakis A; Dalekos GN
Aliment Pharmacol Ther; 2006 Dec; 24(11-12):1563-73. PubMed ID: 17094775
[TBL] [Abstract][Full Text] [Related]
19. Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies.
Calleja JL; Albillos A; Cacho G; Iborra J; Abreu L; Escartín P
J Hepatol; 1996 Mar; 24(3):308-12. PubMed ID: 8778197
[TBL] [Abstract][Full Text] [Related]
20. Organ specificity in autoimmune diseases: thyroid and islet autoimmunity in alopecia areata.
Noso S; Park C; Babaya N; Hiromine Y; Harada T; Ito H; Taketomo Y; Kanto K; Oiso N; Kawada A; Suzuki T; Kawabata Y; Ikegami H
J Clin Endocrinol Metab; 2015 May; 100(5):1976-83. PubMed ID: 25734250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
